Advertisement

  • Finding More Targets for CAR-T Cells

    CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.

    by Kendall K. Morgan

  • Survivor Profile

    Still in the Game

    ESPN reporter Holly Rowe worked through melanoma treatment.

    by Lindsey Konkel

  • More Options for Rare Cancers

    Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.

    by Kendall K. Morgan

  • An Uncommon Partnership

    Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.

    by Ashley P. Taylor

  • Learning to Share

    At first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.

    by Lenn Robbins

  • Brain Cancer Patients Make Connections

    An app developed for glioblastoma patients allows them to track their symptoms and contribute to research.

    by Brad Jones

  • Survivor Profile

    A Second Chance

    After the deaths of her sister and mother from cancer and a bout with osteosarcoma as a teenager, Court Simmons vowed to “do something amazing” with her life. Her goal is to be a pediatric oncology nurse.

    by Lindsey Konkel

  • Q&A

    A Rare Drive

    Chordoma survivor Josh Sommer brings together researchers and patients to develop better treatments for an uncommon cancer.

    by Kate Yandell

  • Survivor Profile

    Betting on Science

    Diagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.

    by Betty Russell

  • Forward Look

    Orphan Drugs Still Find a Home

    Thirty years on, landmark federal legislation continues to benefit patients with rare cancers.

    by Emily Gertz

Advertisement
Advertisement

From the AACR

  • Preventing Cervical Cancer

    Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.

  • New FDA Approvals

    The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.

  • Imaging and Immunotherapy

    Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.

Advertisement

Video

Handle With Care

Advertisement

social media

donate to the AACR